This paper retrospectively compared the incidence of hemolysis before and after a hospital stopped use of 22- gauge needles and exclusively used 23- or 25- gauge needles for blood collection. Levels of serum aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and potassium were also compared in serum from ninety patients with a hemolysis score of 0 or 1 in the 3 months preceding the change and a hemolysis score of ≥2 within 3 months after the change.
Use of finer needles for venipuncture increases in vitro haemolysis despite reducing persistent pain and nerve injury: a retrospective study.
Umemura H, Takahashi H, Fukuda Y, Soma H, Aoki R, Takei N, Nakayama T
Purpose
Conclusion
After the hospital stopped use of 22- gauge needles, a larger percentage of specimens had a hemolysis index ≥1, ≥2, and ≥4. Among the 90 patients that had a blood specimen with a hemolysis score of 0 or 1 within 3 months leading up to the change and a hemolysis score ≥2 within the 3 months after the change, all had higher levels of serum AST, LDH, and potassium in the specimen obtained after the change. Two of these patients had low potassium before the change in needle gauge policy but levels within the reference range after the change in policy. Thus, the authors conclude that the observed increase in hemolysis caused by the change in needle gauge may have masked hypokalaemia.
Studies (1)
Purpose
This study retrospectively compared the incidence of hemolysis before and after a hospital stopped use of 22- gauge needles and exclusively used 23- or 25- gauge needles for blood collection. Levels of serum AST, LDH, and potassium were also compared in serum from ninety patients with a hemolysis score of 0 or 1 in the 3 months preceding the change and a hemolysis score of ≥2 within 3 months after the change. Records from 155,318 serum specimens that were obtained using 22-, 23- and 24- gauge butterfly needles in the year prior to discontinuing the use of 22- gauge butterfly needles and those from 149,963 serum specimens obtained using 23- and 24- gauge needles in the year after the policy change. Further details of specimen handling were not provided. Hemolysis index, AST, LDH, and potassium were assessed using a LABOSPECT 008α automatic biochemical analyzer. An Abbott diagnostic support system was used to identify ninety patients who had a specimen with a hemolysis score of 0 or 1 in the 3 months preceding the policy change and a hemolysis score of ≥2 withing 3 months after the policy change.
Summary of Findings
After the hospital stopped use of 22- gauge needles, a larger percentage of specimens had a hemolysis index ≥1 (4.29% versus 3.5%, P<0.001), ≥2 (1.00% versus 0.625%, P<0.001), and ≥4 (0.283% versus 0.0985%, P<0.001). Among the 90 patients that had a specimen with a hemolysis score of 0 or 1 in the 3 months preceding the policy change and a hemolysis score of ≥2 within 3 months after the change, levels of serum AST, LDH, and potassium were higher in the specimen obtained after the change in all cases (P<0.0001, all). Two of these patients had low potassium prior to the change in needle policy, but levels that were within the reference range after the change. Thus, the authors conclude that the observed increase in hemolysis caused by the change in needle guage may have masked hypokalaemia.
Biospecimens
FluidBloodFluidSerumPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
Electrolyte/MetalClinical chemistry/auto analyzerProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Needle gauge 22-, 23- or 25- gauge butterfly needles23- or 25- gauge butterfly needles